Isosteviol prevents the development of isoprenaline‑induced myocardial hypertrophy
Open Access
- 17 September 2019
- journal article
- research article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 44 (5) , 1932-1942
Abstract
Isosteviol sodium (STVNa), which is a derivate of the natural sweet‑tasting glycoside stevioside, has recently been developed and it has been determined that this compound exhibits neuro‑ and cardio‑protective properties. In the current study, whether STVNa interferes with the development of cardiac hypertrophy, which is induced by isoprenaline (Iso), was investigated in an experimental rat model. Rats were treated with a vehicle (0.9% NaCl; control), isoprenaline (Iso; 5 mg/kg) or Iso (5 mg/kg) with STVNa (4 mg/kg; Iso + STVNa). Cardiomyocytes were isolated using enzymatic dissociation and were treated with 5 µM Iso for 24 h and co‑treated with 5 µM STVNa. Brain natriuretic peptide (BNP) mRNA expression was determined using PCR analysis. Cell surface area, intracellular reactive oxygen species (ROS), mitochondrial transmembrane potential (ΔΨm), cytoplasmic Ca2+ and Ca2+ and contractile function were examined using a laser scanning confocal microscope. The current study demonstrated that STVNa inhibited Iso‑induced cardiac hypertrophy by inhibiting cardiomyocyte size. STVNa significantly reduced cell surface area and decreased BNP mRNA expression in ventricular cardiomyocyte Iso‑induced hypertrophy. STVNa was also revealed to restore ΔΨm and reduce ROS generation and intracellular Ca2+ concentration when compared with the Iso‑treated group. Additionally, STVNa preserved Ca2+ transients in hypertrophic cardiomyocytes. In conclusion, the present study demonstrated that STVNa protects against Iso‑induced myocardial hypertrophy by reducing oxidative stress, restoring ΔΨm and maintaining Ca2+ homeostasis.Keywords
This publication has 39 references indexed in Scilit:
- Nicotinamide-rich diet improves physical endurance by up-regulating SUR2A in the heartJournal of Cellular and Molecular Medicine, 2011
- Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in MiceThe Korean Journal of Physiology & Pharmacology, 2010
- M-LDH physically associated with sarcolemmal KATP channels mediates cytoprotection in heart embryonic H9C2 cellsThe International Journal of Biochemistry & Cell Biology, 2009
- A dual mechanism of cytoprotection afforded by M-LDH in embryonic heart H9C2 cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Isoproterenol-Induced Heart Failure in the Rat is Associated with Nitric Oxide-Dependent Functional Alterations of Cardiac FunctionEuropean Journal of Heart Failure, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Role of Oxidative Stress in Cardiac Hypertrophy and RemodelingHypertension, 2007
- Overexpression of SUR2A generates a cardiac phenotype resistant to ischemiaThe FASEB Journal, 2006
- β -Adrenergic Cardiac Hypertrophy is Mediated Primarily by the β1-Subtype in the Rat HeartJournal of Molecular and Cellular Cardiology, 2001
- Culture of the terminally differentiated adult cardiac muscle cell: A light and scanning electron microscope studyDevelopmental Biology, 1980